Skip to main content
Telehealth NAD

Research digest / get in touch

Contact Telehealth NAD+.

Questions, corrections, and source suggestions about the NAD+ readout — that is what this inbox is for.

Editorial inquiries only

Use the form below for matters about this NAD+ readout: a correction, a question about how a study was summarized, or a peer-reviewed source worth reading. This is a small publishing effort, not a clinic or a vendor — it cannot answer questions about buying, dosing, prescribing, or obtaining NAD+, NMN, NR, or any infusion, because it does none of those things and sells nothing.

Medical advice is out of scope, too. For a health question about NAD+ or its precursors, a qualified healthcare professional who knows your history is the right person to ask — not this inbox.

What to expect

Messages are read in the spirit of keeping the readout accurate. A flagged factual error, or a citation that does not support a claim, is worth knowing and gets checked against the source. No health information is collected, and none should be sent. Please keep submissions to editorial and source-related matters; anything asking for a product, a price, a prescription, or personal medical guidance falls outside what this project does.

Corrections and sources we value most

The submissions that improve the readout most are specific ones. A pointer to a peer-reviewed study that was missed — ideally with a DOI or a PubMed ID — lets a claim be checked against primary literature rather than secondary summaries. A note that a sentence reads as a medical recommendation, when it should read as a description of what a study measured, helps hold the line. And a flag that the coenzyme NAD+ has been blurred with its precursors NMN or NR is always worth sending, because keeping that distinction exact is the discipline this whole project is built on. Not every message can get a reply, but corrections are read and acted on.